Gene · 155
Papers3,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections. | Biomed Pharmacother | 2022 | 35228065 | PubTator, text mining | PubMed |
| Biological Determinants of Metabolic Syndrome in Visceral and Subcutaneous Adipose Tissue from Severely Obese Women. | Int J Mol Sci | 2022 | 35216509 | PubTator, text mining | PubMed |
| Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model. | Int J Mol Sci | 2022 | 35216317 | PubTator, text mining | PubMed |
| Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac Hypertrophy. | Life (Basel) | 2022 | 35207580 | PubTator, text mining | PubMed |
| Reactive Oxygen Species (ROS) and Antioxidants as Immunomodulators in Exercise: Implications for Heme Oxygenase and Bilirubin. | Antioxidants (Basel) | 2022 | 35204062 | PubTator, text mining | PubMed |
| Study Designs for Evaluation of Combination Treatment: Focus on Individual Patient Benefit. | Biomedicines | 2022 | 35203479 | PubTator, text mining | PubMed |
| The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart. | Cells | 2022 | 35203304 | PubTator, text mining | PubMed |
| Protective Effect of Nebivolol against Oxidative Stress Induced by Aristolochic Acids in Endothelial Cells. | Toxins (Basel) | 2022 | 35202159 | PubTator, text mining | PubMed |
| Structural and Functional Diversity of Animal Toxins Interacting With GPCRs. | Front Mol Biosci | 2022 | 35198603 | PubTator, text mining | PubMed |
| Regulatory mechanisms of the early phase of white adipocyte differentiation: an overview. | Cell Mol Life Sci | 2022 | 35184223 | PubTator, text mining | PubMed |
| Activating Human Adipose Tissue with the β3-Adrenergic Agonist Mirabegron. | Methods Mol Biol | 2022 | 35167091 | PubTator, text mining | PubMed |
| Cold Exposure Drives Weight Gain and Adiposity following Chronic Suppression of Brown Adipose Tissue. | Int J Mol Sci | 2022 | 35163791 | PubTator, text mining | PubMed |
| Current Knowledge about the New Drug Firibastat in Arterial Hypertension. | Int J Mol Sci | 2022 | 35163378 | PubTator, text mining | PubMed |
| Endocrine Fibroblast Growth Factors in Relation to Stress Signaling. | Cells | 2022 | 35159314 | PubTator, text mining | PubMed |
| Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling. | Proc Natl Acad Sci U S A | 2022 | 35149557 | PubTator, text mining | PubMed |
| ADRB3 induces mobilization and inhibits differentiation of both breast cancer cells and myeloid-derived suppressor cells. | Cell Death Dis | 2022 | 35145073 | PubTator, text mining | PubMed |
| β-Adrenergic Receptors and Adipose Tissue Metabolism: Evolution of an Old Story. | Annu Rev Physiol | 2022 | 35143333 | PubTator, text mining | PubMed |
| Decoupling Oxygen Tension From Retinal Vascularization as a New Perspective for Management of Retinopathy of Prematurity. New Opportunities From β-adrenoceptors. | Front Pharmacol | 2022 | 35126166 | PubTator, text mining | PubMed |
| Abstracts of the Fourth Brainstorming Research Assembly for Young Neuroscientists (BraYn), Italy, 20-22 October 2021. | Neurol Int | 2022 | 35076571 | PubTator, text mining | PubMed |
| High doses of catecholamines activate glucose transport in human adipocytes independently from adrenoceptor stimulation or vanadium addition. | World J Diabetes | 2022 | 35070058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/155/papers?page=38